• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
TLX
Click for more information
0.51% $17.89

TELIX PHARMACEUTICALS LIMITED

Market Cap $5.955B  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company. The... Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company. The Company is focused on the development and commercialization of diagnostic and therapeutic radiopharmaceuticals and associated medical devices. It is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its core pipeline is focused on prostate cancer, renal cancer, brain cancer (glioma) and rare diseases (hematologic cancers and bone marrow conditioning). Its pipelines include TLX591, TLX592 (alpha-RADmAb), TLX591-CDx, TLX250, TLX250-CDx, TLX101, TLX101-CDx, TLX300, TLX300-CDx, TLX66, and TLX66-CDx. TLX591 is a radio antibody-drug conjugate (rADC) directed at prostate-specific membrane antigen (PSMA). Its product QUANTM Irradiation System (QIS), enables production of important medical isotopes such as gallium-68 (68Ga), zirconium-89 (89Zr), technetium-99m (99mTc) and copper-64 (64Cu).More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
TLX
Short Term trading, analysis and TLX noise - No investors keep out
6 7 8
14:01 478 152K
14:01 Last post  flotsam222 Comments Created with Sketch.  478  Views Created with Sketch.  152K 
TLX
TLX became a Top 100 ASX company 		07:57 20 10K
07:57 Last post  gingerclam Comments Created with Sketch.  20  Views Created with Sketch.  10K 
TLX
Understanding Telix
14 15 16
00:16 938 429K
00:16 Last post  spnc Comments Created with Sketch.  938  Views Created with Sketch.  429K 
TLX
Ann: Telix Completes TLX250-CDx (Zircaix) BLA Submission 		03/06/24 32 9.4K
03/06/24 Last post  flotsam222 Comments Created with Sketch.  32  Views Created with Sketch.  9.4K 
TLX
Ann: ProstACT SELECT Study of TLX591 rADC Therapy - Positive rPFS
2 3
03/06/24 148 46K
03/06/24 Last post  energyraters Comments Created with Sketch.  148  Views Created with Sketch.  46K 
TLX
4 billion market cap breached 		03/06/24 16 8.3K
03/06/24 Last post  spnc Comments Created with Sketch.  16  Views Created with Sketch.  8.3K 
TLX
Telix testing shows efficacy of anti-prostate cancer therapy 		31/05/24 0 317
31/05/24 Last post  TheMarketOnline Comments Created with Sketch.  0  Views Created with Sketch.  317 
TLX
Ann: Update - Application for quotation of securities - TLX 		31/05/24 1 633
31/05/24 Last post  Pomodoro Comments Created with Sketch.  1  Views Created with Sketch.  633 

See All Discussions arrow Created with Sketch.

Timeline

Telix Completes TLX250-CDx (Zircaix) BLA Submission
03 Jun 08:21
 
Update - Application for quotation of securities - TLX
31 May 09:25
 
ProstACT SELECT Study of TLX591 rADC Therapy - Positive rPFS
31 May 08:18
 
Response to ASX Query
28 May 09:58
 
Telix Submits NDA for New Prostate Cancer Imaging Agent
27 May 08:29
 
Becoming a substantial holder from MUFG
22 May 18:05
 
View More arrow Created with Sketch.

Featured News

HZR Hazer Group and POSCO team up to look at low carbon steel
right-arrow Created with Sketch.
CCO Calmer Co taps investors for $2M
right-arrow Created with Sketch.
SPA Spacetalk makes European Market Reentry with Elisa
right-arrow Created with Sketch.
JBY James Bay Minerals jumps 12% as it kicks off exploration run at Joule, Canada
right-arrow Created with Sketch.
EDE Record shale gas and fracking drives demand for Eden's Optiblend in the USA
right-arrow Created with Sketch.
TLX Telix testing shows efficacy of anti-prostate cancer therapy
right-arrow Created with Sketch.
(20min delay)
Last
$17.89 		Change
0.090(0.51%) 		Mkt cap ! $5.955B
Open High Low Value Volume
$17.89 $17.98 $17.57 $14.28M 803.4K

Buyers (Bids)

No. Vol. Price($)
2 1886 $17.89
 

Sellers (Offers)

Price($) Vol. No.
$17.90 1000 1
View Market Depth
Last trade - 16.10pm 05/06/2024 (20 minute delay) ?
Last
$17.90 		  Change
0.090 ( 0.77 %)
Open High Low Volume
$17.91 $17.92 $17.57 132306
Last updated 15.59pm 05/06/2024 ?
TLX (ASX) Chart

Top Stories

The Calmer Co sees shares rise 83% on news of record online sales for May

The Calmer Co International Ltd has reported record online sales for the month of May, sending its shares up 83%.
Daily ASX Market Update: GDP just clears a low bar | June 5, 2024 Australia’s latest Gross Domestic Product data has increased by only 0.1% quarter-on-quarter, after notching 0.3% in Q4 of 2023. The data represents another consecutive expectation miss, with analysts predicting an increase of 0.2%. The data underscores a cooling economy @ and the...
MTM and Murdoch University to collaborate on advanced metallurgy research MTM Critical Metals has signed a MOU with Murdoch University to investigate research and collaboration opportunities for advanced metallurgy opportunities.
Wellnex Life gets set to bring medicinal cannabis to the Australian market Wellnex Life Ltd has announced the launch of new medicinal cannabis brand Wellness Life to the Australian market.
West Cobar wraps up aircore drilling at Salazar West Cobar Metals has completed a program of aircore drilling at its Salazar Critical Minerals Project near Esperance.

Featured News

IMM Immutep targets $100m for lung cancer drug trial tests
right-arrow Created with Sketch.
TLX Telix testing shows efficacy of anti-prostate cancer therapy
right-arrow Created with Sketch.
EDE Record shale gas and fracking drives demand for Eden's Optiblend in the USA
right-arrow Created with Sketch.
CCO Calmer Co taps investors for $2M
right-arrow Created with Sketch.
LU7 Lithium Universe inks final layout for Becancour lithium plant as DFS rolls on
right-arrow Created with Sketch.
I88 Infini boosts WA uranium holdings with Bellah Bore East acquisition
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.